More about Aster DM Healthcare Limited
Fundamentals for Aster DM Healthcare Limited
Regulatory Filings for Aster DM Healthcare Limited
From Cost Center to Strategic Core: The Top 10 Trends Transforming Finance in 2026
CFOs Seize the Tech Purse Strings: How 2026 Budgets Are Fueling the AI Transformation
From Agentic AI to Tokenized Assets: The Fintech Trends Reshaping Financial Services
Forex Focus: How a Weakening Indian Rupee Could Reshape Markets in Q1 2026
Fundamentals for Aster DM Healthcare Limited
Business Operations:
Sector: HealthcareIndustry: Medical Care Facilities
Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare and allied services in India, the United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait and Bahrain, and Republic of Mauritius. It operates through Hospitals, Clinics, Retail Pharmacies, and Others segments. The company operates hospitals and in-house pharmacies at the hospitals; and clinics and in-house pharmacies at the clinics, as well as retail and online pharmacies and optical outlets. It also offers healthcare consultancy and other services. Aster DM Healthcare Limited was founded in 1987 and is headquartered in Dubai, United Arab Emirates.
Revenue projections:
ASTERDM is projected to see lower revenues than in the previous year, a trend that usually concerns investors. Declining revenues often harm a company's profitability, leading investors to exercise caution as they weigh the potential risks of continued financial downturns.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 49.799988 |
| debtToEquity | 43.791000 |
| earningsGrowth | -0.105000 |
| revenueGrowth | 0.130000 |
| grossMargins | 0.558480 |
| operatingMargins | 0.121090 |
| trailingEps | 6.370000 |
| forwardEps | 12.666670 |
Aster DM Healthcare Limited's low earnings and revenue growth indicate potential profit shrinkage. This suggests that the company's financial performance may be weakening, raising concerns about its future profitability and overall business outlook.
Aster DM Healthcare Limited's negative gross and operating margins highlight potential financial struggles, as the company is not covering its production or operational expenses. This could lead to broader concerns about its ability to achieve profitability.
ASTERDM's forward EPS surpasses its trailing EPS, reflecting expectations of higher profitability in the current year. This suggests that ASTERDM is projected to generate stronger earnings, indicating an optimistic financial outlook compared to the prior year's results.
Price projections:
The present price of ASTERDM in relation to its projections indicates a lack of clear risks or opportunities. This balanced situation suggests that investors may find it prudent to wait for further signals before making significant moves in the stock.
Recommendation changes over time:
Analysts' buy bias for ASTERDM signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to ASTERDM, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
Understanding Divergent House Price Movements Worldwide
The 2026 Tariff Tipping Point: When Trade Policy Reaches the Consumer
From Caracas to Commodities: The Market Impact of U.S.–China Friction